Melanoma News and Research

Latest Melanoma News and Research

Research finding offers new approach to treating melanoma

Scientists at Sanford-Burnham Medical Research Institute today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1, plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease.

17 Sep 2013

Data can help scientists, physicians match precision drugs to cancer's genetic traits

More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.

13 Sep 2013

Global Industry Analysis Report on Companion Diagnostics Market

New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

12 Sep 2013

Protein plays important role in process of degradation of tumour cells, say researchers

When tumour cells no longer degrade themselves, cancer may develop. Using black skin cancer as an example, Bern Researchers have now shown that a protein plays an important role in the process of degradation of tumour cells. By reactivating this degradation therapeutically, you can virtually force tumours to digest themselves.

12 Sep 2013

T-rays are ideal for detecting early signs of melanoma

The technology that peeks underneath clothing at airport security screening check points has great potential for looking underneath human skin to diagnose cancer at its earliest and most treatable stages, a scientist said here today.

12 Sep 2013

Roche Signs Up To $422.5M Collaboration With Inovio

...

10 Sep 2013

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

The severity of sleep apnoea can independently predict the aggressiveness of malignant skin melanoma, according to a new study.

10 Sep 2013

Researchers investigate importance of STAT1 phosphorylation in NK cells

Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

...

6 Sep 2013

Viralytics releases financial results for 2013

Viralytics Limited (ASX:VLA, OTCQX:VRACY) has released its financial results for the year ended 30 June 2013.

3 Sep 2013

State highlights: Texas bans youth from tanning salons; Texas, Fla., have most uninsured; Medicare change threatens rural hospital funding in S.D.

Soon, Texas will join a number of states that bar minors from tanning indoors, which experts say greatly increases the risk of melanoma in those under 18. Senate Bill 329, written by State Senators Joan Huffman, Republican of Southside Place, and Sylvia R. Garcia, Democrat of Houston, automatically became law in June without the governor's signature and will take effect on Sunday (Serrano, 8/29).

31 Aug 2013

First Edition: August 30, 2013

Today's headlines include the latest news on congressional efforts to avert a financial crisis as well as coverage of the news from the Internal Revenue Service, Treasury Department and Department of Health and Human Services about how same-sex marriage will be recognized.

30 Aug 2013

Researchers raise awareness about ovarian cancers into synagogues across the country

This fall, the University of Pennsylvania's Basser Research Center for BRCA is taking its lifesaving efforts to raise awareness about hereditary breast and ovarian cancers on the road and into synagogues across the country.

30 Aug 2013

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.

30 Aug 2013

Researchers discover protein that may help predict breast cancer prognosis

Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology.

30 Aug 2013

Experts share tips on preventing ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

29 Aug 2013

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

While it might be nice to pop a pill to protect your skin from the sun, a Loyola University Health System dermatologist warns that oral sunscreens are not as effective as traditional lotions and creams.

29 Aug 2013

Researchers suggest new therapeutic target for brain tumor

Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas — the most common form of brain tumor — suggesting a new target for therapies for a cancer that does not respond to current chemotherapy.

28 Aug 2013

Researchers find specific protein in nearly all high-grade meningiomas

Johns Hopkins researchers say they have found a specific protein in nearly 100 percent of high-grade meningiomas -- the most common form of brain tumor -- suggesting a new target for therapies for a cancer that does not respond to current chemotherapy.

28 Aug 2013

Melanoma News and Research

Latest Melanoma News and Research

Research finding offers new approach to treating melanoma

Data can help scientists, physicians match precision drugs to cancer's genetic traits

Global Industry Analysis Report on Companion Diagnostics Market

Protein plays important role in process of degradation of tumour cells, say researchers

T-rays are ideal for detecting early signs of melanoma

Roche Signs Up To $422.5M Collaboration With Inovio

Severity of sleep apnoea can independently predict aggressiveness of skin melanoma

Researchers investigate importance of STAT1 phosphorylation in NK cells

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

Viralytics releases financial results for 2013

State highlights: Texas bans youth from tanning salons; Texas, Fla., have most uninsured; Medicare change threatens rural hospital funding in S.D.

First Edition: August 30, 2013

Researchers raise awareness about ovarian cancers into synagogues across the country

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

Researchers discover protein that may help predict breast cancer prognosis

Experts share tips on preventing ovarian cancer

Oral sunscreens not as effective as traditional lotions and creams, warns Loyola dermatologist

Researchers suggest new therapeutic target for brain tumor

Researchers find specific protein in nearly all high-grade meningiomas

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Melanoma News and Research

Latest Melanoma News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in